These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 10485701)

  • 1. Akt is more than just a Bad kinase.
    Khwaja A
    Nature; 1999 Sep; 401(6748):33-4. PubMed ID: 10485701
    [No Abstract]   [Full Text] [Related]  

  • 2. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival.
    Chandrasekher G; Sailaja D
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis. A Bad kinase makes good.
    Franke TF; Cantley LC
    Nature; 1997 Nov; 390(6656):116-7. PubMed ID: 9367147
    [No Abstract]   [Full Text] [Related]  

  • 4. Kinase regulation in inflammatory response.
    Delhase M; Li N; Karin M
    Nature; 2000 Jul; 406(6794):367-8. PubMed ID: 10935625
    [No Abstract]   [Full Text] [Related]  

  • 5. Drifting downstream.
    Brooksbank C
    Nat Rev Cancer; 2002 Feb; 2(2):79. PubMed ID: 12635167
    [No Abstract]   [Full Text] [Related]  

  • 6. Calcineurin, mitochondrial membrane potential, and cardiomyocyte apoptosis.
    Molkentin JD
    Circ Res; 2001 Jun; 88(12):1220-2. PubMed ID: 11420294
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances in protein kinase B signalling: AKTion on multiple fronts.
    Brazil DP; Yang ZZ; Hemmings BA
    Trends Biochem Sci; 2004 May; 29(5):233-42. PubMed ID: 15130559
    [No Abstract]   [Full Text] [Related]  

  • 8. Bad can act as a key regulator of T cell apoptosis and T cell development.
    Mok CL; Gil-Gómez G; Williams O; Coles M; Taga S; Tolaini M; Norton T; Kioussis D; Brady HJ
    J Exp Med; 1999 Feb; 189(3):575-86. PubMed ID: 9927519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the Akt/nuclear factor-kappaB signaling axis in developing lung neoplasia.
    Tichelaar JW; Zhang Y; LeRiche JC; Lam S; Anderson MW
    Chest; 2004 May; 125(5 Suppl):153S. PubMed ID: 15136479
    [No Abstract]   [Full Text] [Related]  

  • 10. Signaling pathways in apoptosis as potential targets for cancer therapy.
    Huang P; Oliff A
    Trends Cell Biol; 2001 Aug; 11(8):343-8. PubMed ID: 11489640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IkappaB kinase: beginning, not the end.
    Verma IM; Stevenson J
    Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11758-60. PubMed ID: 9342307
    [No Abstract]   [Full Text] [Related]  

  • 12. Protein kinase B.
    Scheid MP
    Curr Biol; 2000 May; 10(10):R358. PubMed ID: 10837236
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of p53 in male infertility.
    Li J; Huang X; Luo L; Sun J; Guo Q; Yang X; Zhang C; Ni B
    Front Endocrinol (Lausanne); 2024; 15():1457985. PubMed ID: 39469578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of dietary nutrition and TRIB3 action into diabetes mellitus.
    Lu G; Li J; Gao T; Liu Q; Chen O; Zhang X; Xiao M; Guo Y; Wang J; Tang Y; Gu J
    Nutr Rev; 2024 Feb; 82(3):361-373. PubMed ID: 37226405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferroptosis as a Potential Cell Death Mechanism Against Cisplatin-Resistant Lung Cancer Cell Line.
    Golbashirzadeh M; Heidari HR; Talebi M; Yari Khosroushahi A
    Adv Pharm Bull; 2023 Jan; 13(1):176-187. PubMed ID: 36721820
    [No Abstract]   [Full Text] [Related]  

  • 16. Ceritinib (LDK378) prevents bone loss
    He W; Cao X; Kong K; Rong K; Han S; Qin A
    Front Endocrinol (Lausanne); 2022; 13():939959. PubMed ID: 36425467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors - Efficacy, Safety, and Biomarker Results.
    Lindeman GJ; Fernando TM; Bowen R; Jerzak KJ; Song X; Decker T; Boyle F; McCune S; Armstrong A; Shannon C; Bertelli G; Chang CW; Desai R; Gupta K; Wilson TR; Flechais A; Bardia A
    Clin Cancer Res; 2022 Aug; 28(15):3256-3267. PubMed ID: 35583555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCL2L1 is identified as a target of naringenin in regulating ovarian cancer progression.
    Xu J; Guo Z; Yuan S; Li H
    Mol Cell Biochem; 2022 May; 477(5):1541-1553. PubMed ID: 35184257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometriosis-associated Ovarian Clear Cell Carcinoma: A Special Entity?
    Sun Y; Liu G
    J Cancer; 2021; 12(22):6773-6786. PubMed ID: 34659566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive Effect and Molecular Mechanism of
    Subhawa S; Naiki-Ito A; Kato H; Naiki T; Komura M; Nagano-Matsuo A; Yeewa R; Inaguma S; Chewonarin T; Banjerdpongchai R; Takahashi S
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.